Empagliflozin vs Losartan

Empagliflozin vs Losartan: Overview

This comparison examines the pharmacological differences between Empagliflozin and Losartan.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Losartan: Angiotensin II receptor type 1 antagonist.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Losartan — 2 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Losartan — C22H23ClN6O.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Losartan — 422.9200 g/mol.

Type: Empagliflozin — Small molecule; Losartan — Small molecule.